Carlyle Group Inc.
Carlyle Group Inc. reported 19 US-listed holdings worth $10.00 billion in its 13F for the quarter ended 30 June 2026, filed 7 August 2026. Its largest: Medline Inc. (73.8%), StandardAero, Inc. (25.3%) and Phathom Pharmaceuticals Inc. (0.4%). Against the quarter before, it opened 3 positions, added to 2, trimmed 2 and sold out of 4.
Reported holdings$10.00B-5.8% on Q1 2026
Positions19-1 on Q1 2026
The largest ten99.9%of its reported holdings
Latest 13FQ2 2026filed 7 August 2026
OpenedAdded toHeldTrimmed
The 14 largest of its 19 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What it did on the quarter
Opened 3Added 2Held 12Trimmed 2Sold out 4
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Opened 3
- Riley Exploration Permian in REPX$530,387
- Yandex N V NBIS$509,810
- Ramaco Res Inc. METC$287,667
Added to 2
- Complete Solaria Inc. SPWR+1.9 million shares · +441%
- Robinhood Markets, Inc. HOOD+1,357 shares · +40%
Trimmed 2
- Q32 Bio Inc. QTTB-1.0 million shares · -95%
- Invitation Homes Inc. INVH-1,200 shares · -0%
Sold out of 4
- CubeSmart CUBE$8.1 million last quarter
- Heartflow Inc. HTFL$497,256 last quarter
- Spyre Therapeutics Inc. SYRE$485,233 last quarter
- Exicure Inc. XCUR$239,647 last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Medline Inc. MDLN | 187,083,713 | $7.38 billion | 73.78% | no change |
| StandardAero, Inc. SARO | 84,587,035 | $2.53 billion | 25.30% | no change |
| Phathom Pharmaceuticals Inc. PHAT | 3,496,808 | $37.9 million | 0.38% | no change |
| Invitation Homes Inc. INVH | 662,900 | $20.0 million | 0.20% | -1,200 |
| Pony Ai Inc. PONY | 2,362,447 | $16.4 million | 0.16% | no change |
| Getty Images Holdings Inc. GETY | 6,234,252 | $5.4 million | 0.05% | no change |
| Spruce Biosciences Inc. SPRB | 38,620 | $2.1 million | 0.02% | no change |
| Complete Solaria Inc. SPWR | 2,343,750 | $1.6 million | 0.02% | +1,910,592 |
| Adicet Bio Inc. ACET | 184,295 | $1.6 million | 0.02% | no change |
| Forward Air Corp. FWRD | 107,214 | $1.4 million | 0.01% | no change |
| Onkure Therapeutics Inc OKUR | 269,895 | $1.2 million | 0.01% | no change |
| Krispy Kreme Inc. DNUT | 340,748 | $1.2 million | 0.01% | no change |
| Q32 Bio Inc. QTTB | 60,363 | $769,020 | 0.01% | -1,042,378 |
| Riley Exploration Permian in REPX | 16,092 | $530,387 | 0.01% | new |
| Yandex N V NBIS | 1,846 | $509,810 | 0.01% | new |
| Robinhood Markets, Inc. HOOD | 4,733 | $474,625 | 0.00% | +1,357 |
| Jasper Therapeutics Inc. JSPR | 1,066,189 | $448,866 | 0.00% | no change |
| N-able, Inc. NABL | 93,732 | $343,996 | 0.00% | no change |
| Ramaco Res Inc. METC | 21,743 | $287,667 | 0.00% | new |
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.